Clinical trial
NEW ERA STUDY - HIV and Eradication: A Multicenter, Open-label, Non-randomized Trial to Evaluate Treatment With Multi-drug Class (MDC) HAART and Its Impact on the Decay Rate of Latently Infected CD4+ T Cells Incl. Amendment 1.0
NCT00908544 is registered in ClinicalTrials.gov with MUC Research GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NEW ERA STUDY - HIV and Eradication: A Multicenter, Open-label, Non-randomized Trial to Evaluate Treatment With Multi-drug Class (MDC) HAART and Its Impact on the Decay Rate of Latently Infected CD4+ T Cells Incl. Amendment 1.0
- Lead sponsor
- MUC Research GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 15, 2009
- Completion date
- May 31, 2018
- Enrollment
- 47 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.